Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The monocyte-dependent immune response to bacteria is suppressed in smoking-induced COPD.

Knobloch J, Panek S, Yanik SD, Jamal Jameel K, Bendella Z, Jungck D, Bürger P, Bülthoff E, Struck B, Giannakis N, Rupp J, Kronsbein J, Peters M, Koch A.

J Mol Med (Berl). 2019 Jun;97(6):817-828. doi: 10.1007/s00109-019-01778-w. Epub 2019 Mar 30.

PMID:
30929031
2.

Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease.

Knobloch J, Jungck D, Charron C, Stoelben E, Ito K, Koch A.

J Allergy Clin Immunol. 2018 Mar;141(3):1122-1124.e11. doi: 10.1016/j.jaci.2017.09.026. Epub 2017 Nov 21. No abstract available.

PMID:
29079133
3.

The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.

Knobloch J, Jungck D, Koch A.

Curr Mol Med. 2017;17(2):108-117. doi: 10.2174/1566524017666170331162315. Review.

PMID:
28429672
4.

TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6.

Knobloch J, Yanik SD, Körber S, Stoelben E, Jungck D, Koch A.

Biochem Pharmacol. 2016 Sep 15;116:188-99. doi: 10.1016/j.bcp.2016.07.008. Epub 2016 Jul 12.

PMID:
27422754
5.

Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.

Knobloch J, Yakin Y, Körber S, Grensemann B, Bendella Z, Boyaci N, Gallert WJ, Yanik SD, Jungck D, Koch A.

Eur J Pharmacol. 2016 Oct 5;788:294-305. doi: 10.1016/j.ejphar.2016.06.037. Epub 2016 Jun 23.

PMID:
27343379
6.

Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.

Gerlach K, Köhler-Bachmann S, Jungck D, Körber S, Yanik S, Knoop H, Wehde D, Rheinländer S, Walther JW, Kronsbein J, Knobloch J, Koch A.

Eur J Pharmacol. 2015 Dec 5;768:123-30. doi: 10.1016/j.ejphar.2015.10.040. Epub 2015 Oct 23.

PMID:
26526351
7.

A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD.

Knobloch J, Chikosi SJ, Yanik S, Rupp J, Jungck D, Koch A.

Am J Physiol Lung Cell Mol Physiol. 2016 Jan 1;310(1):L24-39. doi: 10.1152/ajplung.00367.2014. Epub 2015 Oct 23.

8.

Endothelin receptor B protects granulocyte macrophage colony-stimulating factor mRNA from degradation.

Jungck D, Knobloch J, Körber S, Lin Y, Konradi J, Yanik S, Stoelben E, Koch A.

J Pharmacol Exp Ther. 2015 Jun;353(3):564-72. doi: 10.1124/jpet.114.215822. Epub 2015 Apr 8.

PMID:
25855530
9.

Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.

Knobloch J, Wahl C, Feldmann M, Jungck D, Strauch J, Stoelben E, Koch A.

Basic Clin Pharmacol Toxicol. 2014 Feb;114(2):202-9. doi: 10.1111/bcpt.12129. Epub 2013 Sep 30.

10.

Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.

Knobloch J, Feldmann M, Wahl C, Jungck D, Behr J, Stoelben E, Koch A.

J Pharmacol Exp Ther. 2013 Aug;346(2):290-9. doi: 10.1124/jpet.112.202358. Epub 2013 May 29.

PMID:
23720457
11.

Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism.

Knobloch J, Lin Y, Konradi J, Jungck D, Behr J, Strauch J, Stoelben E, Koch A.

Am J Respir Cell Mol Biol. 2013 Jul;49(1):114-27. doi: 10.1165/rcmb.2012-0287OC.

PMID:
23590298
12.

Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.

Knobloch J, Hag H, Jungck D, Urban K, Koch A.

Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):138-43. doi: 10.1111/j.1742-7843.2011.00707.x. Epub 2011 May 6.

13.

IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.

Schild K, Knobloch J, Yakin Y, Jungck D, Urban K, Müller K, Koch A.

Int Immunopharmacol. 2011 Apr;11(4):444-8. doi: 10.1016/j.intimp.2010.12.013. Epub 2011 Jan 5.

PMID:
21215348
14.
15.

Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.

Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, Strauch J, Koch A.

J Pharmacol Exp Ther. 2010 Dec;335(3):788-98. doi: 10.1124/jpet.110.166843. Epub 2010 Aug 26.

PMID:
20801891
16.

The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD.

Knobloch J, Schild K, Jungck D, Urban K, Müller K, Schweda EK, Rupp J, Koch A.

Am J Respir Crit Care Med. 2011 Jan 15;183(2):204-14. doi: 10.1164/rccm.201002-0199OC. Epub 2010 Aug 13.

PMID:
20709824
17.

TNFalpha-induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism.

Knobloch J, Peters H, Jungck D, Müller K, Strauch J, Koch A.

Thorax. 2009 Dec;64(12):1044-52. doi: 10.1136/thx.2008.111047. Epub 2009 Oct 22.

PMID:
19850966
18.

[Patient with pain after quadriplegia. From black sheep of the home to favorite of all].

Jungck D.

Schmerz. 2004 Dec;18 Suppl 2:S15-7. German. No abstract available.

PMID:
23570084
19.

Beantragung der ärztlichen Zusatzbezeichnung "Algesiologie" bei den Arztekammern.

Zimmermann M, Flöter T, Jungck D.

Schmerz. 1996 Apr 25;10(2):102-6. German. No abstract available.

PMID:
12799870

Supplemental Content

Loading ...
Support Center